Lucia Lazorova
Forskningsassistent vid Institutionen för farmaceutisk biovetenskap; Forskning; Farmaceutisk fysik
- Telefon:
- 018-471 44 56
- Mobiltelefon:
- 070-167 95 73
- E-post:
- lucia.lazorova@uu.se
- Besöksadress:
- Biomedicinskt centrum BMC, Husargatan 3
- Postadress:
- Box 591
751 24 UPPSALA
Forskningsassistent vid Institutionen för farmaceutisk biovetenskap; Administration och service
- Mobiltelefon:
- 070-167 95 73
- Besöksadress:
- Biomedicinskt centrum BMC, Husargatan 3
- Postadress:
- Box 591
751 24 UPPSALA
- Akademiska meriter:
- PhD
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- Considerations on the quantitative analysis of apparent amorphicity of milled lactose by Raman spectroscopy (2016)
- Combined in Vitro-in Vivo Approach To Assess the Hepatobiliary Disposition of a Novel Oral Thrombin Inhibitor (2013)
- The degree of compression of spherical granular solids controls the evolution of microstructure and bond probability during compaction (2013)
- mRNA expression of drug-transporting proteins along the human intestine and comparison with expression in Caco-2 cells (2012)
- Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: (2011)
Alla publikationer
Artiklar
- Considerations on the quantitative analysis of apparent amorphicity of milled lactose by Raman spectroscopy (2016)
- Combined in Vitro-in Vivo Approach To Assess the Hepatobiliary Disposition of a Novel Oral Thrombin Inhibitor (2013)
- The degree of compression of spherical granular solids controls the evolution of microstructure and bond probability during compaction (2013)
- mRNA expression of drug-transporting proteins along the human intestine and comparison with expression in Caco-2 cells (2012)
- Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: (2011)
- Structural Features Determining the Intestinal Epithelial Permeability and Efflux of Novel HIV-1 Protease Inhibitors (2011)
- Paracellular porosity and pore size of the human intestinal epithelium in tissue and cell culture models (2010)
- CFTR and tight junctions in cultured bronchial epithelial cells (2010)
- Regional levels of drug transporters along the human intestinal tract (2006)
- Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA pK flux a method. (2005)
- Orally active antiviral tripeptide glycyl-prolyl-glycinamide is activated by CD26 (dipeptidyl peptidase IV) before transport across the intestinal epithelium. (2005)
- Ketobemidone is a substrate for cytochrome P4502C9 and 3A4, but not for P-glycoprotein. (2005)
- Exploring the quantitative relationship between the level of MDR1 transcript, protein and function using digoxin as a marker ofMDR1-dependent drug efflux activity. (2004)
- Absorption classification of oral drugs based on molecular surface properties (2003)
- Absorption classification of oral drugs based on molecular surface properties (2003)
- A New Principle for Tight Junction Modulation Based on Occludin Peptides (2003)
- A new principle for tight junction modulation based on occludin peptides (2003)
- Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS (2002)
- Novel lipoamino acid- and liposaccharide-based system for peptide delivery (1999)
- Quantification and imaging of mannitol transport through Caco-2 cell monolayers using a positron-emitting tracer (1998)
- Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate (1998)
- Transport of an influenza virus vaccine formulation (iscom) in Caco-2 cells (1996)
- Particle transcytosis across intestinal epithelial cells exposed for Yersinia pseudotuberculosis: gene expression analysis and functional studies